nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—ABCC10—Cytarabine—lymphatic system cancer	0.142	0.168	CbGbCtD
Estradiol—ABCC10—Vincristine—lymphatic system cancer	0.0671	0.0795	CbGbCtD
Estradiol—CYP1B1—Mitoxantrone—lymphatic system cancer	0.053	0.0628	CbGbCtD
Estradiol—SLC22A2—Cytarabine—lymphatic system cancer	0.0496	0.0587	CbGbCtD
Estradiol—SLC22A1—Cytarabine—lymphatic system cancer	0.0431	0.051	CbGbCtD
Estradiol—SLCO1C1—Methotrexate—lymphatic system cancer	0.0406	0.0481	CbGbCtD
Estradiol—ABCC10—Methotrexate—lymphatic system cancer	0.0406	0.0481	CbGbCtD
Estradiol—SLC22A3—Vincristine—lymphatic system cancer	0.0397	0.047	CbGbCtD
Estradiol—AOX1—Methotrexate—lymphatic system cancer	0.0385	0.0456	CbGbCtD
Estradiol—ABCG2—Teniposide—lymphatic system cancer	0.036	0.0427	CbGbCtD
Estradiol—ABCG2—Mitoxantrone—lymphatic system cancer	0.0252	0.0299	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—lymphatic system cancer	0.0227	0.0269	CbGbCtD
Estradiol—CYP1A2—Carmustine—lymphatic system cancer	0.0221	0.0262	CbGbCtD
Estradiol—SLC22A11—Methotrexate—lymphatic system cancer	0.021	0.0249	CbGbCtD
Estradiol—CYP3A5—Teniposide—lymphatic system cancer	0.02	0.0237	CbGbCtD
Estradiol—ABCG2—Vincristine—lymphatic system cancer	0.0173	0.0205	CbGbCtD
Estradiol—CYP2C19—Teniposide—lymphatic system cancer	0.0161	0.0191	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—lymphatic system cancer	0.014	0.0166	CbGbCtD
Estradiol—CYP2C9—Teniposide—lymphatic system cancer	0.0134	0.0159	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—lymphatic system cancer	0.0132	0.0157	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0128	0.0152	CbGbCtD
Estradiol—CYP3A7—Vincristine—lymphatic system cancer	0.0128	0.0152	CbGbCtD
Estradiol—SLC22A8—Methotrexate—lymphatic system cancer	0.0122	0.0145	CbGbCtD
Estradiol—ABCG2—Methotrexate—lymphatic system cancer	0.0105	0.0124	CbGbCtD
Estradiol—CYP3A5—Vincristine—lymphatic system cancer	0.00961	0.0114	CbGbCtD
Estradiol—ABCB1—Mitoxantrone—lymphatic system cancer	0.00909	0.0108	CbGbCtD
Estradiol—CYP3A4—Cytarabine—lymphatic system cancer	0.0079	0.00936	CbGbCtD
Estradiol—CYP3A4—Teniposide—lymphatic system cancer	0.00779	0.00922	CbGbCtD
Estradiol—ALB—Methotrexate—lymphatic system cancer	0.00724	0.00858	CbGbCtD
Estradiol—ABCB1—Vincristine—lymphatic system cancer	0.00625	0.00741	CbGbCtD
Estradiol—CYP3A4—Mitoxantrone—lymphatic system cancer	0.00545	0.00645	CbGbCtD
Estradiol—ABCB1—Methotrexate—lymphatic system cancer	0.00379	0.00449	CbGbCtD
Estradiol—CYP3A4—Vincristine—lymphatic system cancer	0.00375	0.00444	CbGbCtD
Estradiol—Malaise—Bleomycin—lymphatic system cancer	0.000208	0.00133	CcSEcCtD
Estradiol—Pruritus—Teniposide—lymphatic system cancer	0.000207	0.00133	CcSEcCtD
Estradiol—Cystitis—Methotrexate—lymphatic system cancer	0.000206	0.00132	CcSEcCtD
Estradiol—Cardiac disorder—Vincristine—lymphatic system cancer	0.000205	0.00131	CcSEcCtD
Estradiol—Alopecia—Carmustine—lymphatic system cancer	0.000204	0.00131	CcSEcCtD
Estradiol—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000204	0.00131	CcSEcCtD
Estradiol—Body temperature increased—Fludarabine—lymphatic system cancer	0.000203	0.0013	CcSEcCtD
Estradiol—Mental disorder—Carmustine—lymphatic system cancer	0.000203	0.0013	CcSEcCtD
Estradiol—Vaginal infection—Methotrexate—lymphatic system cancer	0.000201	0.00129	CcSEcCtD
Estradiol—Malnutrition—Carmustine—lymphatic system cancer	0.000201	0.00129	CcSEcCtD
Estradiol—Erythema—Carmustine—lymphatic system cancer	0.000201	0.00129	CcSEcCtD
Estradiol—Cough—Bleomycin—lymphatic system cancer	0.000201	0.00129	CcSEcCtD
Estradiol—Angiopathy—Vincristine—lymphatic system cancer	0.0002	0.00129	CcSEcCtD
Estradiol—Diarrhoea—Teniposide—lymphatic system cancer	0.0002	0.00128	CcSEcCtD
Estradiol—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000199	0.00128	CcSEcCtD
Estradiol—Myalgia—Bleomycin—lymphatic system cancer	0.000196	0.00126	CcSEcCtD
Estradiol—Chest pain—Bleomycin—lymphatic system cancer	0.000196	0.00126	CcSEcCtD
Estradiol—Alopecia—Vincristine—lymphatic system cancer	0.000195	0.00125	CcSEcCtD
Estradiol—Back pain—Carmustine—lymphatic system cancer	0.000195	0.00125	CcSEcCtD
Estradiol—Discomfort—Bleomycin—lymphatic system cancer	0.000194	0.00124	CcSEcCtD
Estradiol—Mental disorder—Vincristine—lymphatic system cancer	0.000193	0.00124	CcSEcCtD
Estradiol—Chills—Mitoxantrone—lymphatic system cancer	0.000193	0.00124	CcSEcCtD
Estradiol—Neoplasm—Methotrexate—lymphatic system cancer	0.000193	0.00124	CcSEcCtD
Estradiol—Urine output increased—Methotrexate—lymphatic system cancer	0.000193	0.00124	CcSEcCtD
Estradiol—Bladder pain—Methotrexate—lymphatic system cancer	0.000193	0.00124	CcSEcCtD
Estradiol—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000191	0.00122	CcSEcCtD
Estradiol—Alopecia—Mitoxantrone—lymphatic system cancer	0.00019	0.00122	CcSEcCtD
Estradiol—Confusional state—Bleomycin—lymphatic system cancer	0.00019	0.00122	CcSEcCtD
Estradiol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000189	0.00121	CcSEcCtD
Estradiol—Tremor—Carmustine—lymphatic system cancer	0.000189	0.00121	CcSEcCtD
Estradiol—Oedema—Bleomycin—lymphatic system cancer	0.000188	0.00121	CcSEcCtD
Estradiol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000188	0.00121	CcSEcCtD
Estradiol—Erythema—Mitoxantrone—lymphatic system cancer	0.000187	0.0012	CcSEcCtD
Estradiol—Infection—Bleomycin—lymphatic system cancer	0.000187	0.0012	CcSEcCtD
Estradiol—Back pain—Vincristine—lymphatic system cancer	0.000186	0.00119	CcSEcCtD
Estradiol—Vomiting—Teniposide—lymphatic system cancer	0.000186	0.00119	CcSEcCtD
Estradiol—Agitation—Carmustine—lymphatic system cancer	0.000185	0.00119	CcSEcCtD
Estradiol—Asthenia—Fludarabine—lymphatic system cancer	0.000184	0.00118	CcSEcCtD
Estradiol—Rash—Teniposide—lymphatic system cancer	0.000184	0.00118	CcSEcCtD
Estradiol—Dermatitis—Teniposide—lymphatic system cancer	0.000184	0.00118	CcSEcCtD
Estradiol—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000183	0.00118	CcSEcCtD
Estradiol—Headache—Teniposide—lymphatic system cancer	0.000183	0.00117	CcSEcCtD
Estradiol—Pruritus—Fludarabine—lymphatic system cancer	0.000182	0.00117	CcSEcCtD
Estradiol—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000181	0.00116	CcSEcCtD
Estradiol—Back pain—Mitoxantrone—lymphatic system cancer	0.000181	0.00116	CcSEcCtD
Estradiol—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000179	0.00115	CcSEcCtD
Estradiol—Agitation—Vincristine—lymphatic system cancer	0.000177	0.00113	CcSEcCtD
Estradiol—Polyuria—Methotrexate—lymphatic system cancer	0.000176	0.00113	CcSEcCtD
Estradiol—Diarrhoea—Fludarabine—lymphatic system cancer	0.000176	0.00113	CcSEcCtD
Estradiol—Hypertension—Carmustine—lymphatic system cancer	0.000174	0.00112	CcSEcCtD
Estradiol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000174	0.00111	CcSEcCtD
Estradiol—Nausea—Teniposide—lymphatic system cancer	0.000173	0.00111	CcSEcCtD
Estradiol—Vertigo—Vincristine—lymphatic system cancer	0.000173	0.00111	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000171	0.0011	CcSEcCtD
Estradiol—Chest pain—Carmustine—lymphatic system cancer	0.000171	0.0011	CcSEcCtD
Estradiol—Myalgia—Carmustine—lymphatic system cancer	0.000171	0.0011	CcSEcCtD
Estradiol—Anxiety—Carmustine—lymphatic system cancer	0.000171	0.0011	CcSEcCtD
Estradiol—Paraesthesia—Bleomycin—lymphatic system cancer	0.000169	0.00108	CcSEcCtD
Estradiol—Malaise—Mitoxantrone—lymphatic system cancer	0.000169	0.00108	CcSEcCtD
Estradiol—Dyspnoea—Bleomycin—lymphatic system cancer	0.000168	0.00108	CcSEcCtD
Estradiol—Hypertension—Vincristine—lymphatic system cancer	0.000166	0.00106	CcSEcCtD
Estradiol—Confusional state—Carmustine—lymphatic system cancer	0.000166	0.00106	CcSEcCtD
Estradiol—Oedema—Carmustine—lymphatic system cancer	0.000164	0.00105	CcSEcCtD
Estradiol—Decreased appetite—Bleomycin—lymphatic system cancer	0.000164	0.00105	CcSEcCtD
Estradiol—Myalgia—Vincristine—lymphatic system cancer	0.000164	0.00105	CcSEcCtD
Estradiol—Visual disturbance—Methotrexate—lymphatic system cancer	0.000163	0.00105	CcSEcCtD
Estradiol—Cough—Mitoxantrone—lymphatic system cancer	0.000163	0.00105	CcSEcCtD
Estradiol—Infection—Carmustine—lymphatic system cancer	0.000163	0.00105	CcSEcCtD
Estradiol—Vomiting—Fludarabine—lymphatic system cancer	0.000163	0.00105	CcSEcCtD
Estradiol—Rash—Fludarabine—lymphatic system cancer	0.000162	0.00104	CcSEcCtD
Estradiol—Dermatitis—Fludarabine—lymphatic system cancer	0.000162	0.00104	CcSEcCtD
Estradiol—Hypertension—Mitoxantrone—lymphatic system cancer	0.000162	0.00104	CcSEcCtD
Estradiol—Pain—Bleomycin—lymphatic system cancer	0.000161	0.00103	CcSEcCtD
Estradiol—Headache—Fludarabine—lymphatic system cancer	0.000161	0.00103	CcSEcCtD
Estradiol—Tachycardia—Carmustine—lymphatic system cancer	0.00016	0.00103	CcSEcCtD
Estradiol—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00016	0.00103	CcSEcCtD
Estradiol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000159	0.00102	CcSEcCtD
Estradiol—Chest pain—Mitoxantrone—lymphatic system cancer	0.000159	0.00102	CcSEcCtD
Estradiol—Myalgia—Mitoxantrone—lymphatic system cancer	0.000159	0.00102	CcSEcCtD
Estradiol—Anxiety—Mitoxantrone—lymphatic system cancer	0.000159	0.00102	CcSEcCtD
Estradiol—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000158	0.00101	CcSEcCtD
Estradiol—Lethargy—Methotrexate—lymphatic system cancer	0.000158	0.00101	CcSEcCtD
Estradiol—Discomfort—Mitoxantrone—lymphatic system cancer	0.000157	0.00101	CcSEcCtD
Estradiol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000157	0.00101	CcSEcCtD
Estradiol—Oedema—Vincristine—lymphatic system cancer	0.000157	0.00101	CcSEcCtD
Estradiol—Infection—Vincristine—lymphatic system cancer	0.000156	0.001	CcSEcCtD
Estradiol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000155	0.000995	CcSEcCtD
Estradiol—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000155	0.000994	CcSEcCtD
Estradiol—Confusional state—Mitoxantrone—lymphatic system cancer	0.000154	0.000988	CcSEcCtD
Estradiol—Nervous system disorder—Vincristine—lymphatic system cancer	0.000154	0.000987	CcSEcCtD
Estradiol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000153	0.00098	CcSEcCtD
Estradiol—Oedema—Mitoxantrone—lymphatic system cancer	0.000153	0.00098	CcSEcCtD
Estradiol—Nausea—Fludarabine—lymphatic system cancer	0.000152	0.000979	CcSEcCtD
Estradiol—Infection—Mitoxantrone—lymphatic system cancer	0.000152	0.000974	CcSEcCtD
Estradiol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000152	0.000973	CcSEcCtD
Estradiol—Shock—Mitoxantrone—lymphatic system cancer	0.00015	0.000964	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00015	0.000961	CcSEcCtD
Estradiol—Urticaria—Bleomycin—lymphatic system cancer	0.000149	0.00096	CcSEcCtD
Estradiol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000149	0.000957	CcSEcCtD
Estradiol—Body temperature increased—Bleomycin—lymphatic system cancer	0.000149	0.000955	CcSEcCtD
Estradiol—Insomnia—Carmustine—lymphatic system cancer	0.000149	0.000954	CcSEcCtD
Estradiol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000148	0.000952	CcSEcCtD
Estradiol—Irritability—Methotrexate—lymphatic system cancer	0.000148	0.000948	CcSEcCtD
Estradiol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000148	0.000948	CcSEcCtD
Estradiol—Paraesthesia—Carmustine—lymphatic system cancer	0.000147	0.000947	CcSEcCtD
Estradiol—Mood swings—Methotrexate—lymphatic system cancer	0.000147	0.000941	CcSEcCtD
Estradiol—Dyspnoea—Carmustine—lymphatic system cancer	0.000146	0.00094	CcSEcCtD
Estradiol—Somnolence—Carmustine—lymphatic system cancer	0.000146	0.000937	CcSEcCtD
Estradiol—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000143	0.000917	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000143	0.000917	CcSEcCtD
Estradiol—Decreased appetite—Carmustine—lymphatic system cancer	0.000143	0.000917	CcSEcCtD
Estradiol—Insomnia—Vincristine—lymphatic system cancer	0.000142	0.00091	CcSEcCtD
Estradiol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000142	0.00091	CcSEcCtD
Estradiol—Paraesthesia—Vincristine—lymphatic system cancer	0.000141	0.000904	CcSEcCtD
Estradiol—Pain—Carmustine—lymphatic system cancer	0.00014	0.000902	CcSEcCtD
Estradiol—Constipation—Carmustine—lymphatic system cancer	0.00014	0.000902	CcSEcCtD
Estradiol—Breast disorder—Methotrexate—lymphatic system cancer	0.00014	0.000898	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000139	0.000893	CcSEcCtD
Estradiol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000139	0.00089	CcSEcCtD
Estradiol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000137	0.00088	CcSEcCtD
Estradiol—Decreased appetite—Vincristine—lymphatic system cancer	0.000136	0.000875	CcSEcCtD
Estradiol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000136	0.000874	CcSEcCtD
Estradiol—Somnolence—Mitoxantrone—lymphatic system cancer	0.000136	0.000871	CcSEcCtD
Estradiol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000135	0.000869	CcSEcCtD
Estradiol—Feeling abnormal—Carmustine—lymphatic system cancer	0.000135	0.000869	CcSEcCtD
Estradiol—Fatigue—Vincristine—lymphatic system cancer	0.000135	0.000868	CcSEcCtD
Estradiol—Asthenia—Bleomycin—lymphatic system cancer	0.000135	0.000867	CcSEcCtD
Estradiol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000134	0.000863	CcSEcCtD
Estradiol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000134	0.000862	CcSEcCtD
Estradiol—Pain—Vincristine—lymphatic system cancer	0.000134	0.000861	CcSEcCtD
Estradiol—Constipation—Vincristine—lymphatic system cancer	0.000134	0.000861	CcSEcCtD
Estradiol—Asthma—Methotrexate—lymphatic system cancer	0.000134	0.000859	CcSEcCtD
Estradiol—Pruritus—Bleomycin—lymphatic system cancer	0.000133	0.000855	CcSEcCtD
Estradiol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000133	0.000852	CcSEcCtD
Estradiol—Fatigue—Mitoxantrone—lymphatic system cancer	0.000132	0.000845	CcSEcCtD
Estradiol—Pancreatitis—Methotrexate—lymphatic system cancer	0.000131	0.000842	CcSEcCtD
Estradiol—Pain—Mitoxantrone—lymphatic system cancer	0.000131	0.000838	CcSEcCtD
Estradiol—Constipation—Mitoxantrone—lymphatic system cancer	0.000131	0.000838	CcSEcCtD
Estradiol—Abdominal pain—Carmustine—lymphatic system cancer	0.00013	0.000833	CcSEcCtD
Estradiol—Body temperature increased—Carmustine—lymphatic system cancer	0.00013	0.000833	CcSEcCtD
Estradiol—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000128	0.000823	CcSEcCtD
Estradiol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000128	0.000823	CcSEcCtD
Estradiol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000126	0.000808	CcSEcCtD
Estradiol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000125	0.000801	CcSEcCtD
Estradiol—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000124	0.000798	CcSEcCtD
Estradiol—Abdominal pain—Vincristine—lymphatic system cancer	0.000124	0.000796	CcSEcCtD
Estradiol—Body temperature increased—Vincristine—lymphatic system cancer	0.000124	0.000796	CcSEcCtD
Estradiol—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000122	0.000784	CcSEcCtD
Estradiol—Urticaria—Mitoxantrone—lymphatic system cancer	0.000121	0.000779	CcSEcCtD
Estradiol—Hypersensitivity—Carmustine—lymphatic system cancer	0.000121	0.000777	CcSEcCtD
Estradiol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000121	0.000775	CcSEcCtD
Estradiol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000121	0.000775	CcSEcCtD
Estradiol—Pneumonia—Methotrexate—lymphatic system cancer	0.00012	0.00077	CcSEcCtD
Estradiol—Vomiting—Bleomycin—lymphatic system cancer	0.00012	0.000768	CcSEcCtD
Estradiol—Infestation NOS—Methotrexate—lymphatic system cancer	0.000119	0.000766	CcSEcCtD
Estradiol—Infestation—Methotrexate—lymphatic system cancer	0.000119	0.000766	CcSEcCtD
Estradiol—Depression—Methotrexate—lymphatic system cancer	0.000119	0.000763	CcSEcCtD
Estradiol—Rash—Bleomycin—lymphatic system cancer	0.000119	0.000762	CcSEcCtD
Estradiol—Dermatitis—Bleomycin—lymphatic system cancer	0.000119	0.000761	CcSEcCtD
Estradiol—Asthenia—Carmustine—lymphatic system cancer	0.000118	0.000756	CcSEcCtD
Estradiol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000116	0.000744	CcSEcCtD
Estradiol—Hypersensitivity—Vincristine—lymphatic system cancer	0.000116	0.000742	CcSEcCtD
Estradiol—Haematuria—Methotrexate—lymphatic system cancer	0.000114	0.00073	CcSEcCtD
Estradiol—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000113	0.000724	CcSEcCtD
Estradiol—Epistaxis—Methotrexate—lymphatic system cancer	0.000113	0.000722	CcSEcCtD
Estradiol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000113	0.000722	CcSEcCtD
Estradiol—Asthenia—Vincristine—lymphatic system cancer	0.000113	0.000722	CcSEcCtD
Estradiol—Diarrhoea—Carmustine—lymphatic system cancer	0.000112	0.000721	CcSEcCtD
Estradiol—Nausea—Bleomycin—lymphatic system cancer	0.000112	0.000717	CcSEcCtD
Estradiol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00011	0.000703	CcSEcCtD
Estradiol—Dizziness—Carmustine—lymphatic system cancer	0.000109	0.000697	CcSEcCtD
Estradiol—Haemoglobin—Methotrexate—lymphatic system cancer	0.000108	0.000691	CcSEcCtD
Estradiol—Diarrhoea—Vincristine—lymphatic system cancer	0.000107	0.000689	CcSEcCtD
Estradiol—Haemorrhage—Methotrexate—lymphatic system cancer	0.000107	0.000687	CcSEcCtD
Estradiol—Hepatitis—Methotrexate—lymphatic system cancer	0.000107	0.000687	CcSEcCtD
Estradiol—Pharyngitis—Methotrexate—lymphatic system cancer	0.000106	0.000682	CcSEcCtD
Estradiol—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000106	0.000679	CcSEcCtD
Estradiol—Urethral disorder—Methotrexate—lymphatic system cancer	0.000105	0.000674	CcSEcCtD
Estradiol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000104	0.000671	CcSEcCtD
Estradiol—Vomiting—Carmustine—lymphatic system cancer	0.000104	0.00067	CcSEcCtD
Estradiol—Dizziness—Vincristine—lymphatic system cancer	0.000104	0.000666	CcSEcCtD
Estradiol—Rash—Carmustine—lymphatic system cancer	0.000104	0.000665	CcSEcCtD
Estradiol—Dermatitis—Carmustine—lymphatic system cancer	0.000103	0.000664	CcSEcCtD
Estradiol—Visual impairment—Methotrexate—lymphatic system cancer	0.000103	0.000662	CcSEcCtD
Estradiol—Headache—Carmustine—lymphatic system cancer	0.000103	0.00066	CcSEcCtD
Estradiol—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000101	0.00065	CcSEcCtD
Estradiol—Eye disorder—Methotrexate—lymphatic system cancer	0.0001	0.000642	CcSEcCtD
Estradiol—Tinnitus—Methotrexate—lymphatic system cancer	9.98e-05	0.000641	CcSEcCtD
Estradiol—Vomiting—Vincristine—lymphatic system cancer	9.97e-05	0.00064	CcSEcCtD
Estradiol—Cardiac disorder—Methotrexate—lymphatic system cancer	9.94e-05	0.000638	CcSEcCtD
Estradiol—Rash—Vincristine—lymphatic system cancer	9.89e-05	0.000635	CcSEcCtD
Estradiol—Dermatitis—Vincristine—lymphatic system cancer	9.88e-05	0.000634	CcSEcCtD
Estradiol—Headache—Vincristine—lymphatic system cancer	9.82e-05	0.000631	CcSEcCtD
Estradiol—Nausea—Carmustine—lymphatic system cancer	9.76e-05	0.000626	CcSEcCtD
Estradiol—Angiopathy—Methotrexate—lymphatic system cancer	9.72e-05	0.000624	CcSEcCtD
Estradiol—Vomiting—Mitoxantrone—lymphatic system cancer	9.71e-05	0.000623	CcSEcCtD
Estradiol—Immune system disorder—Methotrexate—lymphatic system cancer	9.67e-05	0.000621	CcSEcCtD
Estradiol—Mediastinal disorder—Methotrexate—lymphatic system cancer	9.65e-05	0.000619	CcSEcCtD
Estradiol—Rash—Mitoxantrone—lymphatic system cancer	9.63e-05	0.000618	CcSEcCtD
Estradiol—Dermatitis—Mitoxantrone—lymphatic system cancer	9.62e-05	0.000617	CcSEcCtD
Estradiol—Chills—Methotrexate—lymphatic system cancer	9.61e-05	0.000617	CcSEcCtD
Estradiol—Headache—Mitoxantrone—lymphatic system cancer	9.57e-05	0.000614	CcSEcCtD
Estradiol—Alopecia—Methotrexate—lymphatic system cancer	9.46e-05	0.000607	CcSEcCtD
Estradiol—Mental disorder—Methotrexate—lymphatic system cancer	9.38e-05	0.000602	CcSEcCtD
Estradiol—Malnutrition—Methotrexate—lymphatic system cancer	9.32e-05	0.000598	CcSEcCtD
Estradiol—Erythema—Methotrexate—lymphatic system cancer	9.32e-05	0.000598	CcSEcCtD
Estradiol—Nausea—Vincristine—lymphatic system cancer	9.31e-05	0.000598	CcSEcCtD
Estradiol—Dysgeusia—Methotrexate—lymphatic system cancer	9.13e-05	0.000586	CcSEcCtD
Estradiol—Nausea—Mitoxantrone—lymphatic system cancer	9.07e-05	0.000582	CcSEcCtD
Estradiol—Back pain—Methotrexate—lymphatic system cancer	9.02e-05	0.000579	CcSEcCtD
Estradiol—Ill-defined disorder—Methotrexate—lymphatic system cancer	8.65e-05	0.000555	CcSEcCtD
Estradiol—Malaise—Methotrexate—lymphatic system cancer	8.41e-05	0.00054	CcSEcCtD
Estradiol—Vertigo—Methotrexate—lymphatic system cancer	8.38e-05	0.000538	CcSEcCtD
Estradiol—Cough—Methotrexate—lymphatic system cancer	8.13e-05	0.000522	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—lymphatic system cancer	7.94e-05	0.000509	CcSEcCtD
Estradiol—Chest pain—Methotrexate—lymphatic system cancer	7.94e-05	0.000509	CcSEcCtD
Estradiol—Myalgia—Methotrexate—lymphatic system cancer	7.94e-05	0.000509	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	7.88e-05	0.000506	CcSEcCtD
Estradiol—Discomfort—Methotrexate—lymphatic system cancer	7.84e-05	0.000503	CcSEcCtD
Estradiol—Confusional state—Methotrexate—lymphatic system cancer	7.67e-05	0.000492	CcSEcCtD
Estradiol—Anaphylactic shock—Methotrexate—lymphatic system cancer	7.61e-05	0.000488	CcSEcCtD
Estradiol—Infection—Methotrexate—lymphatic system cancer	7.56e-05	0.000485	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—lymphatic system cancer	7.46e-05	0.000479	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—lymphatic system cancer	7.39e-05	0.000474	CcSEcCtD
Estradiol—Hyperhidrosis—Methotrexate—lymphatic system cancer	7.36e-05	0.000472	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	6.93e-05	0.000445	CcSEcCtD
Estradiol—Insomnia—Methotrexate—lymphatic system cancer	6.88e-05	0.000442	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—lymphatic system cancer	6.83e-05	0.000439	CcSEcCtD
Estradiol—Dyspnoea—Methotrexate—lymphatic system cancer	6.78e-05	0.000435	CcSEcCtD
Estradiol—Somnolence—Methotrexate—lymphatic system cancer	6.76e-05	0.000434	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—lymphatic system cancer	6.7e-05	0.00043	CcSEcCtD
Estradiol—Decreased appetite—Methotrexate—lymphatic system cancer	6.61e-05	0.000425	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	6.57e-05	0.000422	CcSEcCtD
Estradiol—Fatigue—Methotrexate—lymphatic system cancer	6.56e-05	0.000421	CcSEcCtD
Estradiol—Pain—Methotrexate—lymphatic system cancer	6.51e-05	0.000418	CcSEcCtD
Estradiol—Feeling abnormal—Methotrexate—lymphatic system cancer	6.27e-05	0.000402	CcSEcCtD
Estradiol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	6.22e-05	0.000399	CcSEcCtD
Estradiol—Urticaria—Methotrexate—lymphatic system cancer	6.04e-05	0.000388	CcSEcCtD
Estradiol—Abdominal pain—Methotrexate—lymphatic system cancer	6.01e-05	0.000386	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—lymphatic system cancer	6.01e-05	0.000386	CcSEcCtD
Estradiol—Hypersensitivity—Methotrexate—lymphatic system cancer	5.61e-05	0.00036	CcSEcCtD
Estradiol—Asthenia—Methotrexate—lymphatic system cancer	5.46e-05	0.00035	CcSEcCtD
Estradiol—Pruritus—Methotrexate—lymphatic system cancer	5.38e-05	0.000346	CcSEcCtD
Estradiol—Diarrhoea—Methotrexate—lymphatic system cancer	5.21e-05	0.000334	CcSEcCtD
Estradiol—Dizziness—Methotrexate—lymphatic system cancer	5.03e-05	0.000323	CcSEcCtD
Estradiol—Vomiting—Methotrexate—lymphatic system cancer	4.84e-05	0.00031	CcSEcCtD
Estradiol—Rash—Methotrexate—lymphatic system cancer	4.8e-05	0.000308	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—lymphatic system cancer	4.79e-05	0.000308	CcSEcCtD
Estradiol—Headache—Methotrexate—lymphatic system cancer	4.77e-05	0.000306	CcSEcCtD
Estradiol—Nausea—Methotrexate—lymphatic system cancer	4.52e-05	0.00029	CcSEcCtD
